62
Views
9
CrossRef citations to date
0
Altmetric
Original Research

The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer

, , , , , , , , , & show all
Pages 10125-10133 | Published online: 02 Dec 2019

References

  • Streicher J, Meyerson BL. A review of optimal prostate biopsy: indications and techniques.Ther Advan Urol. 2019;11:1756287219870074.31489033
  • American Cancer Society. Cancer Facts & Figures 2018. Atlanta, GA: American Cancer Society; 2018.
  • Sim HG, Cheng CWS. Changing demography of prostate cancer in Asia. Eur J Cancer. 2005;41(6):834–845. doi:10.1016/j.ejca.2004.12.03315808953
  • Climent MA, Leon-Mateos L, Gonzalez Del Alba A, et al. Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer. Crit Rev Oncol Hematol. 2015;96(2):308–318.26100652
  • Quon H, Loblaw DA. Androgen deprivation therapy for prostate cancer – review of indications in 2010. Curr Oncol. 2010;17(Suppl 2):S38–44. doi:10.3747/co.v17i0.69820882131
  • Gioeli D. Signal transduction in prostate cancer progression. Clin Sci. 2005;108(4):293–308. doi:10.1042/CS2004032915603554
  • Golabek T, Belsey J, Drewa T, et al. Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer. Cent European J Urol. 2016;69(2):131–138. doi:10.5173/ceju.2016.812
  • Li Q, Huang H, He Z, et al. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells. Sci China Life Sci. 2018;61(5):550–558. doi:10.1007/s11427-016-9050-629119376
  • Huang H, Wang Q, Du T, et al. Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B. Prostate. 2018;78(5):327–335.29356020
  • Li Q, Lai Y, Wang C, et al. Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-kappaB signaling pathway. Oncol Rep. 2016;35(1):375–381.26497618
  • Vaz CV, Marques R, Alves MG, et al. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. J Cancer Res Clin Oncol. 2016;142(1):5–16. doi:10.1007/s00432-015-1992-426048031
  • Scher HI, Heller G, Molina A, et al. Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. J Clin Oncol. 2015;33(12):1348–1355. doi:10.1200/JCO.2014.55.348725800753
  • Keshari KR, Sriram R, Van Criekinge M, et al. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Prostate. 2013;73(11):1171–1181. doi:10.1002/pros.v73.1123532911
  • De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7(4):256–269. doi:10.1038/nrc209017384581
  • Thapa D, Ghosh R. Chronic inflammatory mediators enhance prostate cancer development and progression. Biochem Pharmacol. 2015;94(2):53–62. doi:10.1016/j.bcp.2014.12.02325593038
  • Staverosky JA, Zhu XH, Ha S, Logan SK. Anti-androgen resistance in prostate cancer cells chronically induced by interleukin-1beta. Am J Clin Exp Urol. 2013;1(1):53–65.25374900
  • Yencilek F, Yildirim A, Yilmaz SG, et al. Investigation of interleukin-1beta polymorphisms in prostate cancer. Anticancer Res. 2015;35(11):6057–6061.26504029
  • Xu H, Hu MB, Bai PD, et al. Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet. Biomed Res Int. 2015;2015:249741.25722971
  • Liu JM, Liu JN, Wei MT, et al. Effect of IL-18 gene promoter polymorphisms on prostate cancer occurrence and prognosis in Han Chinese population. Genet Mol Res. 2013;12(1):820–829. doi:10.4238/2013.March.15.223546966
  • Dwivedi S, Goel A, Natu SM, Mandhani A, Khattri S, Pant KK. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study. Asian Pac J Cancer Prev. 2011;12(7):1843–1848.22126577
  • Tse BW, Russell PJ, Lochner M, Forster I, Power CA. IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PLoS ONE. 2011;6(9):e24241. doi:10.1371/journal.pone.002424121935389